QGRW WisdomTree U.S. Quality Growth Fund

Expense Ratio
0.28%
Dividend
0.09%
Previous close
$54.10
Est. 12 months change
+33.11%
Projected Price
$72.01

Profitability Metrics

Return on Equity (ROE)
57.40%
Return on Assets (ROA)
18.71%
Return on Invested Capital (ROIC)
50.10%
Weighted Average Cost of Capital (WACC)
11.66%
ROIC - WACC
38.44%
Updated : 2026-04-03 19:48 ET

Valuation Metrics

P/E Ratio
33.63
Forward P/E
22.95
PEG Ratio
1.54
Debt Current Ratio
2.18

Growth & Cash Flow

Gross Margin
61.75%
Operating Margin
34.79%
FCF Margin
26.06%
TTM Revenue Growth
32.44%
Projected 12M EPS Growth
46.55%

Price Change

Price % from 50 SMA
-4.23%
Price % from 200 SMA
-4.20%
6 Months
-6.40%
1 Year
20.81%
2 Years
32.44%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA14.58%
GOOGL8.85%
META7.34%
MSFT6.89%
AAPL6.63%
AMZN4.26%
AVGO3.65%
LLY2.96%
TSLA2.78%
MU2.56%

ETF Analysis

Fund Overview

WisdomTree U.S. Quality Growth Fund (QGRW) currently reports 100 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is NVDA (14.58%), GOOGL (8.85%), META (7.34%), with NVDA as the largest single weight at 14.58%. Together, the top three holdings account for 30.77%, which implies that short-term performance can be meaningfully influenced by a narrow set of large constituents. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 50.10%, WACC is 11.66%, and the economic spread is 38.44%. On balance, the underlying businesses generate returns on capital that dramatically exceed their funding costs — a rare and powerful compounding dynamic. Supporting metrics show ROE at 57.40% and ROA at 18.71%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 33.63, forward P/E of 22.95, PEG of 1.54. A meaningful compression from trailing to forward P/E implies analysts are projecting earnings growth that could re-rate the portfolio favorably if delivered. The PEG ratio signals a portfolio priced at reasonable growth-adjusted value — adequate for the earnings outlook, without offering an obvious margin of safety. The current ratio of 2.18 is in an acceptable range, reflecting reasonable short-term financial health. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 61.75%, operating margin at 34.79%, and free cash flow margin at 26.06%. The gross margin here is a standout, pointing to businesses with durable unit economics and limited commodity exposure. Exceptional operating margins signal that overhead costs are well managed relative to the revenue base. Outstanding free cash flow margins signal businesses that convert revenues into cash at rates that support both reinvestment and shareholder returns. All three margin layers are constructive, pointing to a portfolio where quality of earnings is high and cash generation is reliable.

Growth & Forward Outlook

Projected 12-month EPS growth of 46.5% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Turning to growth and analyst expectations, TTM revenue growth of 32.44% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 33.44%, where analyst targets indicate a strong re-rating opportunity from current prices. The distinction matters: revenue growth tells you what the businesses are doing, price targets tell you what analysts think the market will pay for it. Ultimately, the alignment between revenue momentum and analyst targets will depend on execution quality and the broader rate and sentiment environment. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The quantitative profile, taken as a whole, is above average on virtually every dimension that matters for long-term return generation.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.